Antiviral Activity of Phytochemicals: A Current Perspective

  • Rajesh Naithani
  • Rajendra G. Mehta
  • Deepak Shukla
  • Susantha N. Chandersekera
  • Robert M. Moriarty
Part of the Nutrition and Health book series (NH)

Key Points

A wide variety of active phytochemicals have been found to have therapeutic ­applications against genetically and functionally diverse viruses. The antiviral mechanism of these agents may be explained on the basis of their ­antioxidant activities, scavenging capacities, the inhibition of DNA, RNA synthesis, or the blocking of viral reproduction, etc. Numerous epidemiological and experimental studies have revealed that a large number of phytochemicals have promising antiviral activities. Especially in the last decade, a number of promising leads have been identified by a combination of in vitro and in vivo studies using diverse biological assays.

Key Words

Antiviral phytochemical infection replication flavonoids clinical ­trials mechanism 


  1. 1.
    Solecki RS (1975) Shanidar IV, a Neanderthal flower burial in northern Iraq. Science 190:880–881Google Scholar
  2. 2.
    International Symposium on Medicinal Plants, April 19–21, 1993, in Philadelphia, USA. The Morris Arboretum and the World Health Organization (WHO)Google Scholar
  3. 3.
    Fabricant DS, Farnsworth NR (2001) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109(Suppl 1):69–75PubMedGoogle Scholar
  4. 4.
    Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432:829–837PubMedCrossRefGoogle Scholar
  5. 5.
    Cardellina JH (2002) Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 65:1073–1084PubMedCrossRefGoogle Scholar
  6. 6.
    Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O’Neal JM, Cornwell T, Pastor I, Fridlender B (2002) Plants and human health in the twenty-first century. Trends Biotechnol 20:522–531PubMedCrossRefGoogle Scholar
  7. 7.
    Pietta P, Gardana C, Pietta A (2003) Flavonoids in health. In: Rice-Evans C, Packer L (eds) Flavonoids in health and disease, 2nd edn. Marcel Dekker, New York, NY, p 43Google Scholar
  8. 8.
    Selway JWT (1986) Antiviral activity of flavones and flavans. In: Cody V, Middleton E, Harborne JB (eds) Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure–activity relationships. Liss, A.R, New York, NYGoogle Scholar
  9. 9.
    Martin KW, Ernst E (2003) Antiviral agents from plants and herbs: a systematic review. Antivir Ther 8(2):77–90PubMedGoogle Scholar
  10. 10.
    Naithani R, Huma L, Holland LE Shukla D, Mccormick DL, Mehta RM, Moriarty RM (2008) Antiviral activity of phytochemicals: a comprehensive review. Mini Rev Med Chem 8(11):1106PubMedCrossRefGoogle Scholar
  11. 11.
    Okeke IN, Laxmaninarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, Pablos-Mendez A, Klugman KP (2005) Antimicrobial resistance in developing countries. Part 1: recent trends and current status. Lancet Infect Dis 5:481–493PubMedCrossRefGoogle Scholar
  12. 12.
    Rose RE, Gong YF, Greytok JA, Bechtold CM, Terry BJ, Robinson BS, Alam M, Colonno RJ, Lin PF (1996) Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors. Proc Natl Acad Sci USA 93:1648PubMedCrossRefGoogle Scholar
  13. 13.
    Balfour HH (1999) Antiviral drugs. N Engl J Med 340:1255PubMedCrossRefGoogle Scholar
  14. 14.
    Kuper H, Adami HO, Trichopoulos D (2000) Infections as a major preventable cause of human cancer. J Int Med 48:171CrossRefGoogle Scholar
  15. 15.
    Patwardhan B (2005) Ethnopharmacology and drug discovery. J Ethnopharm 100:50–52CrossRefGoogle Scholar
  16. 16.
    Cordell GA, Colvard MD (2005) Some thoughts on the future of ethnopharmacology. J Ethnopharm 100:5–14CrossRefGoogle Scholar
  17. 17.
    Hudson JB, Graham EA, Towers GHN (1994) Antiviral assays on phytochemicals: the influence of reaction parameters. Planta Med 60:329–332PubMedCrossRefGoogle Scholar
  18. 18.
    Jensik SC, Northrop RL (1971) Incorporation of radioactive seleno-(75Se)-methionine into mumps virus. Appl Microbiol 21(3):451–455PubMedGoogle Scholar
  19. 19.
    Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N (2007) Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: chemical diversity, impacts on plant biology and human health. Biotechnol J 2(10):1214PubMedCrossRefGoogle Scholar
  20. 20.
    Spencer JP (2008) Flavonoids: modulators of brain function? Br J Nutr 99:ES60–ES77PubMedGoogle Scholar
  21. 21.
    Thomas PRS, Nash GB, Dormandly JA (1988) White cells accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J 296:1673Google Scholar
  22. 22.
    Loewenstein WR (1979) Junctional intercellular communication and the control of growth. Biochem Biophys Acta 560:1PubMedGoogle Scholar
  23. 23.
    Gerdin B, Srensso E (1983) Inhibitory effect of flavonoids on increased microvascular permeability induced by various agents in rat skin. Int J Microcir Clin Exp 2:39Google Scholar
  24. 24.
    Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N (2006) Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Bioorg Med Chem 14:3785PubMedCrossRefGoogle Scholar
  25. 25.
    Nowakowska Z (2007) A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 42:125PubMedCrossRefGoogle Scholar
  26. 26.
    Phrutivorapongkul A, Lipipun V, Ruangrungsi N, Kirtikara K, Nishikawa K, Maruyama S, Watanabe T, Ishikawa T (2003) Studies on the chemical constituents of stem bark of Millettia leucantha: isolation of new chalcones with cytotoxic, anti-herpes simplex virus and anti-inflammatory activities. Chem Pharm Bull 51:187PubMedCrossRefGoogle Scholar
  27. 27.
    Likhitwitayawuid K, Chaiwiriyaa S, Sritularaka B, Lipipunb V (2006) Antiherpetic flavones from the heartwood of Artocarpus gomezianus. Chem Biodivers 3:1138PubMedCrossRefGoogle Scholar
  28. 28.
    Prendergast PT (2003) US Patent No 6555523Google Scholar
  29. 29.
    Santhosh C, Mishra PC (1996) Molecular electrostatic potential mapping and structure-activity relationship for 3-methoxy flavones. Indian J Biochem Biophys 33(6):458PubMedGoogle Scholar
  30. 30.
    Moriarty RM, Surve BC, Naithani R, Chandersekera SN, Tiwari V, Shukla D (2007) Synthesis and antiviral activity of Abyssinone II analogs. In: Abstracts of papers, 233rd ACS National Meeting, Chicago, IL, 25–29 March 2007Google Scholar
  31. 31.
    Zhao Yu, Wang F, Liu W, Bai H. (2007) Method for preparation and application dihydroflavanonol compounds. Faming Zhuanli Shenqing Gongkai Shuomingshu 34Google Scholar
  32. 32.
    Ren Q, Song X (2005) Use of a composition containing dihydromyricetin and myricetin in preparation of antiviral medicines. Faming Zhuanli Shenqing Gongkai Shuomingshu 20Google Scholar
  33. 33.
    Andersen, O. M, Helland, D. E, Andersen, K. J. (1997) Anthocyanidin and anthocyanidin derivatives, and their isolation, for treatment of cancer, diseases caused by lesions in connective tissues, and diseases caused by viruses. PCT Int Appl 121Google Scholar
  34. 34.
    Takatsuki A, Tamura G, Arima K (1969) Antiviral and antitumor antibiotics. XIV. Effects of ascochlorin and other respiration inhibitors on multiplication of Newcastle disease virus in cultured cells. App Microbiol 17:825Google Scholar
  35. 35.
    Mashava P (1996) PCT Int Appl 38Google Scholar
  36. 36.
    Conti C, Orsi N, Stein ML (1988) Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells. Antiviral Res 10:117PubMedCrossRefGoogle Scholar
  37. 37.
    Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee K-H (2003) Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 23:322PubMedCrossRefGoogle Scholar
  38. 38.
    Creagh T, Ruckle JL, Tolbert DT (2001) Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrob Agents Chem 45:1379CrossRefGoogle Scholar
  39. 39.
    Li Y, Leung KT, Yao F, Ooi LSM, Ooi VEC (2006) Antiviral flavans from the leaves of Pithecellobium clypearia. J Nat Prod 69:833PubMedCrossRefGoogle Scholar
  40. 40.
    Charles L, Laure F, Raharivelomanana P, Bianchini JP (2005) Sheath liquid interface for the coupling of normal-phase liquid chromatography with electrospray mass spectrometry and its application to the analysis of neoflavonoids. J Mass Spectrom 40:75PubMedCrossRefGoogle Scholar
  41. 41.
    Farnsworth NR (2006) Biological and phytochemical screening of plants. J Pharm Sci 55(3):225CrossRefGoogle Scholar
  42. 42.
    Houghton PJ, Woldemariam TZ, Khan AI, Burke A, Mahmood N (1994) Antiviral activity of natural and semi-synthetic chromosome alkaloids. Antiviral Res 25(3–4):235PubMedCrossRefGoogle Scholar
  43. 43.
    Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, Lee CK, Chang ST, Kuo CJ, Lee SS, Hou CC, Hsiao PW, Chien SC, Shyur LF, Yang NS (2007) Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 50:4087PubMedCrossRefGoogle Scholar
  44. 44.
    Melikian G, Mmiro F, Ndugwa C, Perry R, Jackson JB, Garrett E, Tielsch J, Semba RD (2001) Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus. Nutrition 17:567PubMedCrossRefGoogle Scholar
  45. 45.
    Heldreth B, Turos E (2005) N-Thiolated beta-lactam antibacterials: effects of the N-organothio substituent on anti-MRSA activity. Curr Med Chem 4:295Google Scholar
  46. 46.
    Hunter R, Caira M, Stellenboom N (2005) Nat Prod Mol Ther 6:234Google Scholar
  47. 47.
    Moriarty RM, Naithani R, Surve BC, Tiwari V, Shukla D (2006) Synthesis and antiviral activity of Sulforamate derivatives. In: Abstracts-233rd ACS National Meeting Chicago, IL, 25–29 March 2006Google Scholar
  48. 48.
    Jariwalla R, Harakeh S (1996) Antiviral and immunomodulatory activities of ascorbic acid. In: Harris JR (ed) Subcellular biochemistry: ascorbic acid: biochemistry and biomedical cell biology, vol 25. Plenum, New York, p 215CrossRefGoogle Scholar
  49. 49.
    Andreone P, Fiorino S, Cursaro C, Gramenzi A, Margotti M, Di Giammarino L, Biselli M, Miniero R, Gasbarrini G, Bernardi M (2001) Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial. Antiviral Res 49:75PubMedCrossRefGoogle Scholar
  50. 50.
    Cermelli C, Vinceti M, Scaltriti E, Bazzani E, Beretti F, Vivoli G, Portolani M (2002) Selenite inhibition of Coxsackie virus B5 replication: implications on the etiology of Keshan disease. J Trace Elem Med Biol 16:41PubMedCrossRefGoogle Scholar
  51. 51.
    La Colla P, Tramontano E, Musiu C, Marongiu ME, Novellino E, Greco G, Massa S, Di Santo R, Costi R, Marino A (1998) In vitro and in vivo antiproliferative activity of IPCAP, a new pyrazole. Antiviral Res 7:A57Google Scholar
  52. 52.
    Botelho MV, Orlandi JM, de Melo FL, Mantovani MS, Linhares RE, Nozawa C (2004) Chlorophyllin protects HEp-2 cells from nuclear fragmentation induced by poliovirus. Lett Appl Microbiol 39:174PubMedCrossRefGoogle Scholar
  53. 53.
    Ishihara C, Yoshimatsu K, Tsuji M, Arikawa J, Saiki I, Tokura S, Azuma I (1993) Antiviral activity of sulfated chitin. Vaccine 11:670PubMedCrossRefGoogle Scholar
  54. 54.
    Liu KC, Lin MT, Lee SS, Chiou JF, Ren S, Lien EJ (1999) Antiviral tannins from two Phyllanthus species. Planta Med 65:43PubMedCrossRefGoogle Scholar
  55. 55.
    Hudson JB (1990) Antiviral compounds from plants. CRC, Boca Raton, FLGoogle Scholar
  56. 56.
    Wat CK, Biswas RK, Graham EA, Bohm L, Towers GH, Waygood ER (1979) Ultraviolet-mediated cytotoxic activity of phenylheptatriyne from Bidens pilosa. J Nat Prod 42:103PubMedCrossRefGoogle Scholar
  57. 57.
    Neushul M (1990) Antiviral carbohydrates from marine red algae. Hydrobiologia 205:99CrossRefGoogle Scholar
  58. 58.
    Gerber P, Dutcher JD, Adams EV, Sherman JH (1958) Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus. Proc Soc Exp Biol Med 99:590PubMedGoogle Scholar
  59. 59.
    Witvrouw M, DeClerq E (1997) Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol 29:497PubMedCrossRefGoogle Scholar
  60. 60.
    Huleihel M, Ishanu V, Tal J, Arad SM (2001) Antiviral effect of red microalgal polysaccharide on Herpes simplex and Varicella zoster viruses. J Appl Phycol 13:127CrossRefGoogle Scholar
  61. 61.
    Konigheim BS, Goleniowski ME, Contigiani MS (2005) Citotoxicity and antiviral activity of a lignan extracted from Larrea divaricata. Drug Des Rev 2:81Google Scholar
  62. 62.
    Wang CY, Sun SW, Lee SS (2004) Pharmacokinetic and metabolic studies of retrojusticidin B, a potential antiviral lignan, in rats. Planta Med 70:1161PubMedCrossRefGoogle Scholar
  63. 63.
    Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY (2007) Emodin blocks the SARS coronavirus spike ­protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 74:92PubMedCrossRefGoogle Scholar
  64. 64.
    Chrubasik S, Pittler MH, Roufogalis BD (2005) Zingiberis rhizome: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 12:684PubMedCrossRefGoogle Scholar
  65. 65.
    Singh DP, Moore CA, Gilliland A, Carr JP (2004) Activation of multiple antiviral defence mechanisms by salicylic acid. Mol Plant Pathol 5:57PubMedCrossRefGoogle Scholar
  66. 66.
    Semple SJ, Pyke GD, Reynolds SM, Flower RLP (2001) In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Res 49:169PubMedCrossRefGoogle Scholar
  67. 67.
    Wang W, Zu Y, Fu Y, Reichling J, Suschke U, Nokemper S, Zhang Y (2009) In vitro antioxidant, antimicrobial and anti-herpes simplex virus type 1 activity of Phellodendron amurense China. Am J Chin Med 37(1):195–203PubMedCrossRefGoogle Scholar
  68. 68.
    Amoros M, Simoes CMO, Girre L (1992) Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 155:1732–1740CrossRefGoogle Scholar
  69. 69.
    Min BS, Tomiyama M, Ma CM, Nakamura N, Hattori M (2001) Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase. Chem Pharm Bull 49:546–550PubMedCrossRefGoogle Scholar
  70. 70.
    McLaughlin JL (2008) Paw paw and cancer: annonaceous acetogenins from discovery to commercial products. J Nat Prod 71(7):1311–1321PubMedCrossRefGoogle Scholar
  71. 71.
    Phongpaichit S, Nikom J, Rungjindamai N, Sakayaroj J, Hutadilok-Towatana N, Rukachaisirikul V, Kirtikara K (2007) Biological activities of extracts from endophytic fungi isolated from Garcinia plants. FEMS Immunol Med Microbiol 51(3):517–525PubMedCrossRefGoogle Scholar
  72. 72.
    Cos P, Maes L, Vander Berghe D, Hermen N, Pieters L, Vlietinck A (2004) Plant substances as Anti-HIV agents selected according to their putative mechanism of action. J Nat Prod 67:284–293PubMedCrossRefGoogle Scholar
  73. 73.
    Yoosook C, Bunyapraphatsara N, Boonakiat Y, Kantasuk C (2000) Anti-herpes simplex virus activities of crude water extract of Thai medicinal plants. Phytomedicine 6:411–419PubMedCrossRefGoogle Scholar
  74. 74.
    Dias DA, Silva CA, Urban S (2009) Naphthalene aglycones and glycosides from Australian medicinal plant, Dianella callicarpa. Planta Med 75((13)):1442–1447CrossRefGoogle Scholar
  75. 75.
    Petrera E, Coto CE (2009) Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L, in mice genital herpetic infection. Phytother Res 23(12):1771–1777PubMedCrossRefGoogle Scholar
  76. 76.
    Alvarez AL, Del Barrio G, Kourí V, Martínez PA, Suárez B, Parra F (2009) In vitro anti-herpetic activity of an aqueous extract from the plant Phyllanthus orbicularis. Phytomedicine 16(10):960–966PubMedCrossRefGoogle Scholar
  77. 77.
    Lee LS, Andrade AS, Flexner C (2006) Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects. Clin Infect Dis 43(8):1052PubMedCrossRefGoogle Scholar
  78. 78.
    Ishitsuka H, Ohsawa C, Ohiwa T, Umeda I, Suhara Y (1982) Antipicornavirus flavone Ro 09-0179. Antimicrob Agents Chemother 22:611PubMedCrossRefGoogle Scholar
  79. 79.
    Serkedjieva J (1995) Inhibition of influenza virus protein synthesis by a plant preparation from Geranium sanguineum L. Acta Virol 39(1):5–10PubMedGoogle Scholar
  80. 80.
    Malhotra B, Onyilagha JC, Bohm BA, Towers GHN, James D, Harborne JB, French CJ (1996) Inhibition of tomato ringspot virus by flavonoids. Phytochemistry 43:1271CrossRefGoogle Scholar
  81. 81.
    Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM (2000) Flavonoid baicalin inhibits HIV infection at the level of viral entry. Biochem Biophysical Res Comm 276:534CrossRefGoogle Scholar
  82. 82.
    Eversa DL, Chaoa CF, Wanga X, Zhanga Z, Huonga SM, Huang ES (2005) Antiviral Res 68:124CrossRefGoogle Scholar
  83. 83.
    Castrillo JL, Carrasco L (1987) Action of 3-methylquercetin on poliovirus RNA replication. J Virol 61:3319PubMedGoogle Scholar
  84. 84.
    Takechi M, Tanaka Y (1981) Purification and characterization of antiviral substance from the bud of Syzygium aromatica. Planta Med 42:69PubMedCrossRefGoogle Scholar
  85. 85.
    Sydiskis RJ, Owen DG, Lohr JL, Rosler KH, Blomster RN (1991) Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 35:2463PubMedCrossRefGoogle Scholar
  86. 86.
    Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, Kawana T, Shiraki K (1998) Purification and characterization of eugeniin as an anti-herpes virus compounds from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther 284:728PubMedGoogle Scholar
  87. 87.
    Bettega JMR, Teixeira H, Bassani VL, Barardi CRM, Simões MO (2004) Evaluation of the antiherpetic activity of standardized extracts of Achyrocline satureioides. Phytother Res 18:819PubMedCrossRefGoogle Scholar
  88. 88.
    Spedding G, Ratty A, Middleton E (1989) Inhibition of reverse transcriptases by flavonoids. Antiviral Res 12:99PubMedCrossRefGoogle Scholar
  89. 89.
    Salvati AL, De Dominicis A, Tait S, Canitan A, Lahm A, Fiore L (2004) Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus. Antimicrob Agents Chemother 48:2233PubMedCrossRefGoogle Scholar
  90. 90.
    Song JM, Lee KH, Seong BL (2005) Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 68:66PubMedCrossRefGoogle Scholar
  91. 91.
    Lin YM, Flavin MT, Schure R, Chen FC, Sidwell R, Barnard DL, Huffman JH, Kern ER (1999) Antiviral activities of biflavonoids. Planta Med 65:120PubMedCrossRefGoogle Scholar
  92. 92.
    Semple SJ, Nobbs SF, Pyke SM, Reynolds GD, Flower RL (1999) Antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine. J Ethnopharmacol 68:283PubMedCrossRefGoogle Scholar
  93. 93.
    Yu YB, Miyashiro H, Nakamura N, Hattori M, Cheol PJ (2007) Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Arch Pharm Res 30:820PubMedCrossRefGoogle Scholar
  94. 94.
    Hwanga DR, Wua YS, Changa CW, Liena TW, Chena WC, Tanb UK, Hsua JTA, Hsieh HP (2006) Synthesis and antiviral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system. Bioorg Med Chem 14:83CrossRefGoogle Scholar
  95. 95.
    González ME, Alarcón B, Carrasco L (1987) Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother 31:1388PubMedCrossRefGoogle Scholar
  96. 96.
    Talyshinsky MM, Souprun YY, Huleihe MM (2002) Antiviral activity of red microalgal polysaccharides against retroviruses. Cancer Cell Int 2:8PubMedCrossRefGoogle Scholar
  97. 97.
    McMahon JB, Currens MJ, Gulakowski RJ, Buckheit RW Jr, Lackman-Smith C, Hallock YF, Boyd MR (1995) Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrob Agents Chemother 39:484PubMedCrossRefGoogle Scholar
  98. 98.
    Renard-Nozaki J, Kim T, Imakura Y, Kihara M, Kobayashi S (1989) Effect of alkaloids isolated from Amaryllidaceae on herpes simplex virus. Res Virol 140:115PubMedCrossRefGoogle Scholar
  99. 99.
    Bresnahan WA, Boldogh I, Chi P, Thompson EA, Albrecht T (1997) Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239PubMedCrossRefGoogle Scholar
  100. 100.
    Schang LM, Phillips J, Schaffer PA (1998) Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol 72:5626PubMedGoogle Scholar
  101. 101.
    Redfield DC, Oxman RDD, MN KLH (2001) Rapid serological technique for typing herpes simplex viruses. Infect Immun 32:1216Google Scholar
  102. 102.
    Durantel D, Branza-Nichita N, Carrouée-Durantel S, Butters TD, Dwek RA, Zitzmann N (2001) Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J Virol 75:8987PubMedCrossRefGoogle Scholar
  103. 103.
    Marles RJ, Hudson JB, Graham EA, Soucy-Breau C, Morand P, Compadre RL, Compadre CM, Towers GH, Arnason JT (1992) Structure-activity studies of photoactivated antiviral and cytotoxic tricyclic thiophenes. Photochem Photobiol 56:479PubMedCrossRefGoogle Scholar
  104. 104.
    Stanberry LR, Bourne N, Bravo FJ, Bernstein DI (1992) Capsaicin-sensitive peptidergic neurons are involved in the zosteriform spread of herpes simplex virus infections. J Med Virol 38:142PubMedCrossRefGoogle Scholar
  105. 105.
    Si X, Wang Y, Wong J, Zhang J, McManus BM, Luo H (2007) Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol 81:3142PubMedCrossRefGoogle Scholar
  106. 106.
    Dikici I, Mehmetoglu I, Dikici N, Bitirgen M, Kurban S (2005) Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment. Clin Biochem 38:1141PubMedCrossRefGoogle Scholar
  107. 107.
    Joint United Nations Programme on HIV/AIDS (2006) Overview of the global AIDS epidemic. 2006 Report on the global AIDS epidemic, UNAIDS, Geneva, SwitzerlandGoogle Scholar
  108. 108.
    Paris A, Strukelj B, Renko M, Turk V, Pukl M, Umek A, Korant BD (1993) Inhibitory effect of carnosolic acid on HIV-1 protease in cell-free assays. J Nat Prod 56:1426PubMedCrossRefGoogle Scholar
  109. 109.
    Chang CT, Doong SL, Tsai IL, Chen IS (1997) Coumarins and anti-HBV constituents from Zanthoxylum schinifolium. Phytochemistry 45:1419CrossRefGoogle Scholar
  110. 110.
    Fortin H, Tomasi S, Jaccard P, Robin V, Boustie J (2001) A prenyloxycoumarin from Psiadia dentata. Chem Pharm Bull 49:619PubMedCrossRefGoogle Scholar
  111. 111.
    Sakagami H, Asano K, Satoh K, Takahashi K, Kobayashi M, Koga N, Takahashi H, Tachikawa R, Tashiro T, Hasegawa A, Kurihara K, Ikarashi T, Kanamoto T, Terakubo S, Nakashima H, Watanabe S, Nakamura W (2007) Anti-stress, anti-HIV and vitamin C-synergized radical scavenging activity of mulberry juice fractions. In Vivo 21:499PubMedGoogle Scholar
  112. 112.
    Hsieh P-W, Chang F-R, Lee K-H, Hwang T-L, Chang SM, Wu YC (2004) A new anti-HIV alkaloid, drymaritin, and a new C-glycoside flavonoid, diandraflavone, from Drymaria diandra. J Nat Prod 67:1175PubMedCrossRefGoogle Scholar
  113. 113.
    Lee JS, Kim HJ, Lee YS (2003) A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium. Planta Med 69:859PubMedCrossRefGoogle Scholar
  114. 114.
    Olivero-Verbel J, Pacheco-Londono L (2002) Structure activity relationships for the anti-HIV activity of flavonoids. J Chem Inf Comput Sci 42:1241PubMedCrossRefGoogle Scholar
  115. 115.
    Nishibe S, Ono K, Nakane H, Kawamura T, Noro Y, Tanaka T (1997) Inhibitory effects of flavonoids from Plantago species on HIV reverse transcriptase activity. Nat Med 51:547Google Scholar
  116. 116.
    Kim HJ, Woo ER, Shin CG, Park H (1998) A new flavol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus (HIV-1) integrase. J Nat Prod 61:145PubMedCrossRefGoogle Scholar
  117. 117.
    Critchfield JW, Butera ST, Folks TM (1996) Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 12:39PubMedCrossRefGoogle Scholar
  118. 118.
    Mahmood N, Pizza C, Aquino R, De Tommasi N, Piacente S, Colman S, Burke A, Hay AJ (1993) Inhibition of HIV infection by flavanoids. Antiviral Res 22:189PubMedCrossRefGoogle Scholar
  119. 119.
    Schinazi RF, Chu CK, Babu JRB, Oswald V, Saalman DL, Erickson BF (1990) Anthraquinones as a new class of antiviral agents against AIDS. Antiviral Res 13:265PubMedCrossRefGoogle Scholar
  120. 120.
    Robin V, Boustie J, Amoros M, Girre L (1998) In-vitro antiviral activity of seven Psiadia species. Pharmacol Commun 4:61Google Scholar
  121. 121.
    Tuli V (1974) Mechanism of the antiviral action of 3-methyleneoxindole. Antimicrob Agents Chemother 5(5):485PubMedCrossRefGoogle Scholar
  122. 122.
    Lyu S-Y, Rhim JY, Park WB, Lyu SY, Rhim JY, Park WB (2005) Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). Arch Pharm Res 28:1293PubMedCrossRefGoogle Scholar
  123. 123.
    Ma W, Ma X, Huang H, Zhou P, Chen D (2007) Lignans and triterpenoids from the stems of Kadsura induta. Chem Biodivers 4:966PubMedCrossRefGoogle Scholar
  124. 124.
    Chattopadhyay D (2007) In: Ahmad I, Aqil F, Owais M (eds) Ethnomedicinal antivirals: scope and opportunity modern phytomedicine, p 313Google Scholar
  125. 125.
    Benencia F, Courrèges MC (2000) In vitro and in vivo activity of eugenol on human herpesvirus. Phytother Res 14:495PubMedCrossRefGoogle Scholar
  126. 126.
    Li H, Zhou CX, Pan Y, Gao X, Wu X, Bai H, Zhou L, Chen Z, Zhang S, Shi S, Luo J, Xu J, Chen L, Zheng X, Zhao Y (2005) Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus. Planta Med 71:1128PubMedCrossRefGoogle Scholar
  127. 127.
    Likhitwitayawuid K, Supudompol B, Sritularak B, Lipipun V, Rapp K, Schinazi RF (2005) Phenolics with anti-HSV and anti-HIV activities from Artocarpus gomezianus, Mallotus pallidus and Triphasia trifolia. Pharm Biol 43:651CrossRefGoogle Scholar
  128. 128.
    El Sohly HN, El-Feraly FS, Joshi AS, Walker LA (1997) Antiviral flavonoids from Alkanna orientalis. Planta Med 63:384CrossRefGoogle Scholar
  129. 129.
    Lin LC, Kuo YC, Chou CJ (2000) Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of Limonium sinense. Planta Med 66:333PubMedCrossRefGoogle Scholar
  130. 130.
    Du J, He ZD, Jiang RW, Ye WC, Xu HX, But PP (2003) Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry 62:1235–1238PubMedCrossRefGoogle Scholar
  131. 131.
    Jou S-J, Chen C-H, Guh J-H, Lee C-N, Lee SS (2004) Flavonol glycosides and cytotoxic triterpenoids from Alphitonia philippinensis. J Chin Chem Soc (Taipei, Taiwan) 51:827Google Scholar
  132. 132.
    Atta-ur-Rahman (ed) (1995) Studies in natural products chemistry, structure and chemistry, vol 17, Part D. Elsevier, AmsterdamGoogle Scholar
  133. 133.
    Loizzo M, Saab A, Tundis R, Statti G, Lampronti I, Menichini F, Gambari R, Cinatl J, Doerr H (2008) Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Phytomedicine 15:79–83PubMedCrossRefGoogle Scholar
  134. 134.
    Harden EA, Falshaw R, Carnachan SM, Kern ER, Prichard MN (2009) Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antiviral Res 83(3):282–289PubMedCrossRefGoogle Scholar
  135. 135.
    Bunyapraphatsara N, Dechsree S, Yoosook C, Herunsalee A, Panpisutchai Y (2000) Anti-herpes simplex virus component isolated from Maclura cochinchinensis. Phytomedicine 6:421PubMedCrossRefGoogle Scholar
  136. 136.
    Okamoto T, Kanda T (1999) Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression. Int J Mol Med 4:149–152PubMedGoogle Scholar
  137. 137.
    Shin MS, Kang EH, Lee YI (2005) A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antiviral Res 67:163PubMedCrossRefGoogle Scholar
  138. 138.
    Cai SQ, Wang R, Yang X, Shang M, Ma C, Shoyama Y (2006) Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis. Chem Biodivers 3:343PubMedCrossRefGoogle Scholar
  139. 139.
    Nagai T, Suzuki Y, Tomimori T, Yamada H (1995) Antiviral activity of plant flavonoid, 5, 7, 4′-trihydroxy-8-methoxyflavone, from roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull 18:95Google Scholar
  140. 140.
    Sidwell RW, Huffman JH, Moscon BJ, Warren RP (1994) In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy 40:42PubMedCrossRefGoogle Scholar
  141. 141.
    Quaglia MG, Desideri N, Bossu E, Sgro R, Conti C (1999) Enantioseparation and anti-rhinovirus activity of 3-benzylchroman-4-ones. Chirality 11(5–6):495–500PubMedCrossRefGoogle Scholar
  142. 142.
    Douglas RM, Chalker EB, Treacy B (2000) Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2:CD000980PubMedGoogle Scholar
  143. 143.
    Melchart D, Linde K, Fischer P, Kaesmayr J (2000) Echinacea for preventing and treating the common cold [Review]. Cochrane Database Syst Rev (2):CD000530Google Scholar
  144. 144.
    Desideri N, Conti C, Mastromarino P, Mastropaolo F (2000) Synthesis and anti-rhinovirus activity of 2-styrylchromones. Antivir Chem Chemother 11:373PubMedGoogle Scholar
  145. 145.
    Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG (1992) In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 58:417PubMedCrossRefGoogle Scholar
  146. 146.
    Tait S, Salvati AL, Desideri N, Fiore L (2006) Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antiviral Res 72:252PubMedCrossRefGoogle Scholar
  147. 147.
    Singh S, Malik BK, Sharma DK (2007) Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Chem Biol Drug Des 69:191PubMedCrossRefGoogle Scholar
  148. 148.
    Amaral ACF, Kuster RM, Goncalves JLS, Wigg MD (1999) Phytochemical investigation of an antiviral fraction of Chamaesyce thymifolia. Fitoterapia 70:293CrossRefGoogle Scholar
  149. 149.
    Desideri N, Oliveri S, Stein ML, Sgro R, Orsi N, Conti C (1997) Synthesis and anti-rhinovirus activity of 2-styrylchromones. Antivir Chem Chemother 8:545Google Scholar
  150. 150.
    Chiang LC, Chiang W, Liu MC, Lin CC (2003) In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother 52:194PubMedCrossRefGoogle Scholar
  151. 151.
    Moriarty RM, Naithani R, Hirtopeanu A, Gao K, Kazerani S, Badlani R, Staszewski JP, Zitzmann, N, Dwek, RA, Jacob, GS, Picker D, Mehta A, Block TM. N-Alkyl deoxynojirimycins as antiviral compounds. In: Abstracts of papers, 224th ACS National Meeting, Boston, MA, 18-22 August 2002Google Scholar
  152. 152.
    Mehta A, Ouzounov S, Jordan R, Simsek E, Lu X, Moriarty RM, Jacob G, Dwek RA, Block TM (2002) Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ. Antivir Chem Chemother 13:299PubMedGoogle Scholar
  153. 153.
    De Almeida AP, Miranda MMFS, Simoni IC, Wigg MD, Lagrota MHC, Costa SS (1998) Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion. Phytotherapy Res 12:562CrossRefGoogle Scholar
  154. 154.
    Li Y, Ooi LS, Wang H, But PP, Ooi VE (2004) Antiviral activities of medicinal herbs traditionally used in southern mainland China. Phytother Res 18:718–722PubMedCrossRefGoogle Scholar
  155. 155.
    Lipipun V, Kurokawa M, Suttisri R, Taweechotipatr P, Pramyothin P, Hattori M, Shiraki K (2003) Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res 60:175–180PubMedCrossRefGoogle Scholar
  156. 156.
    Arthan D, Svasti J, Kitaakoop P, Pittayakhachonwut D, Toem M, Thebtaranonth Y (2002) Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum. Phytochem 59:459–463CrossRefGoogle Scholar
  157. 157.
    Aspers S, Baronikova S, Sindambiwe JB, Witvrouwm M, De Clercqm E, Vanden Berghe D, Van Maeck E (2001) Antiviral, haemolytic and molluscicidal activities of triterpenoid saponins from Maesa lanceolata: establishment of structure-activity relationships. Planta Med 67:521Google Scholar
  158. 158.
    Sydiskis RJ, Owen DG, Lohr JL, Rosler KH, Blomster N (1999) Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 35:2463–2666CrossRefGoogle Scholar
  159. 159.
    Jassim SA, Naji MA (2003) Novel antiviral agents: A medicinal plant perspective. J Appl Microbiol 95:412–417PubMedCrossRefGoogle Scholar
  160. 160.
    Garcia CC, Talarico L, Almeida N, Colombres S, Duschatzky C, Damonte EB (2003) Virucidal activity of essential oils from aromatic plants of San Luis, Argentina. Phytother Res 17:1073–1075PubMedCrossRefGoogle Scholar
  161. 161.
    Alche LE, Berra A, Veloso MJ, Coto CE (2000) Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice. J Med Virol 61:474–480PubMedCrossRefGoogle Scholar
  162. 162.
    Baermejo P, Abad MJ, Diaz AM, Ferenandez L, Santos JD, Sachez S, Vallaescusa L, Carrasco L, Irurzun A (2002) Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med 68:106–110CrossRefGoogle Scholar
  163. 163.
    Primo V, Rovera M, Zanon S, Oliva M, Demo M, Daghero J, Sabini L (2001) Determination of the antibacterial and antiviral activity of the essential oil from Minthostachys verticillata (Griseb.). Rev Argent Microbiol 33:113–117PubMedGoogle Scholar
  164. 164.
    Khan MT, Ather A, Thompson KD, Gambari R (2005) Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res 67:107–119PubMedCrossRefGoogle Scholar
  165. 165.
    Chattopadhyay D, Arunachalam G, Mandal AB, Bhattacharya SK (2006) Dose-dependent therapeutic antiinfectives from ethnomedicines of bay islands. Chemotherapy 52(3):151–157PubMedCrossRefGoogle Scholar
  166. 166.
    Cheng HY, Lin CC, Lin TC (2002) Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res 55:447–455PubMedCrossRefGoogle Scholar
  167. 167.
    Allahveridev A, Duran N, Ozguven M, Koltas S (2004) Investigation of the anticancerogenic effect of the essential oil of Melissa officinalis L. Phytomedicine 11:657CrossRefGoogle Scholar
  168. 168.
    Ojo OO, Oluyege JO, Famurewa O (2009) Antiviral properties of two Nigerian plants African. J Plant Sci 3(7):157–159Google Scholar
  169. 169.
    Chiang LC, Cheng HY, Liu MC, Chiang W, Lin CC (2003) In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditionally used medicinal plants in Taiwan. Biol Pharm Bull 26:1600–1604PubMedCrossRefGoogle Scholar
  170. 170.
    Choi HJ, Song HJ, Park KS, Kwon DH (2009) Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci 3–4:329–333CrossRefGoogle Scholar
  171. 171.
    Kernan MT, Amarquaye A, Chen JL, Chan J, Sesin DF, Parkinson N, Ye Z, Barrett M (1998) Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea. J Nat Prod 61:564–570PubMedCrossRefGoogle Scholar
  172. 172.
    Wei F, Ma SC, Ma LY, But PP, Lin RC, Khan IA (2004) Antiviral flavonoids from the seeds of Aesculus chinensis. J Nat Prod 67:650–653PubMedCrossRefGoogle Scholar
  173. 173.
    Rajbhandari M, Wegner U, Schopke T, Lindequist U, Mentel R (2003) Inhibitory effect of Bergenia ligulata on influenza virus. Pharmazie 58:268–271PubMedGoogle Scholar
  174. 174.
    Sokmen M, Angeova M, Krumova E, Peshova S, Ivancheva S, Sokmen A, Serkedijieva J (2005) In vitro antioxidant activity of polyphenol extracts with antiviral properties from Geranium sanguineum. Life Sci 76:2981–2993PubMedCrossRefGoogle Scholar
  175. 175.
    Olila D, Olwa-Odyejk A, Opudo A (2002) Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro. J Afr Health Sci 2:2–10Google Scholar
  176. 176.
    Thyagarajan SP, Subramanian S, Thirunalasundari TN, Venkateswaran PS, Blumberg BS (1998) Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 2(8614):764–766Google Scholar
  177. 177.
    Thyagarajan SP, Jayaram S, Valiammai TT (1990) Phyllanthus amarus and hepatitis B. Lancet 336:949–950PubMedCrossRefGoogle Scholar
  178. 178.
    Liu J, Zhu M, Shi R, Yang M (2003) Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med 31:337–354PubMedCrossRefGoogle Scholar
  179. 179.
    Ho TY, Wu SL, Lai IL, Cheng KS, Kao ST, Hsiang CY (2003) An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors. Antiviral Res 58:199PubMedCrossRefGoogle Scholar
  180. 180.
    Sekine-Osajima Y, Sakamoto N, Nakagawa M, Itsui Y, Tasaka M, Nishimura-Sakurai Y, Chen CH, Suda G, Mishima K, Onuki Y, Yamamoto M, Maekawa S, Enomoto N, Kanai T, Tsuchiya K, Watanabe M (2009) Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. Hepatol Res 39(1):60–69PubMedCrossRefGoogle Scholar
  181. 181.
    Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Uberla K, Uberla K (2009) Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach. Chemotherapy 55:119–126PubMedCrossRefGoogle Scholar
  182. 182.
    Manfredi KP, Vallurupalli V, Demidova M, Kindscher K, Pannell LK (2001) Isolation of anti-HIV diprenylated bibenzyl from Glycyrrhiza lepidota. Phytochemistry 58:153–157PubMedCrossRefGoogle Scholar
  183. 183.
    Wu JH, Wang XH, Yi YH, Lee KH (2003) A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg Med Chem Lett 13:1813–1815PubMedCrossRefGoogle Scholar
  184. 184.
    Chang YS (2003) Woo ER (2003) Korean medicinal plants inhibiting to human immunodeficiency virus type 1 (HIV-1) fusion. Phytother Res 17:426–429PubMedCrossRefGoogle Scholar
  185. 185.
    Balzarini JC, Daelemans BD, Meertens M, Cornier EG, Reinus JF, Peumans WJ, Van Damme EJM, Oki YIT, Schols D, Dragic T (2007) Carbohydrate-binding agents (CBAs) selectively target the glycoproteins of the HCV and HIV envelope to prevent viral entry. Antiviral Res 74:A43CrossRefGoogle Scholar
  186. 186.
    Yogeeswari P, Sriram D (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12:657–666PubMedCrossRefGoogle Scholar
  187. 187.
    Jay J, Lai B, Kiser P (2009) Multivalent synthetic lectin polymers against HIV. Antiviral Res 82:A63–A64CrossRefGoogle Scholar
  188. 188.
    Gosse B, Gnabre J, Bates RB, Dicus CW, Nakkiew P, Huangg RC (2002) Antiviral saponins from Tieghemella heckelii. J Nat Prod 65:1942–1944PubMedCrossRefGoogle Scholar
  189. 189.
    Ma CM, Nakamura N, Miyashiro H, Hattori M, Komatsu K, Kawahata T, Otake T (2002) Screening of Chinese and Mongolian herbal drugs for anti-human immunodeficiency virus type 1 (HIV-1) activity. Phytother Res 16:186–189PubMedCrossRefGoogle Scholar
  190. 190.
    Shikishima Y, Takaishi Y, Honda G, Ito M, Takfda Y, Kodzhimatov OK, Ashurmetov O, Lee KH (2001) Chemical constituents of Prangos tschimganica; structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity. Chem Pharm Bull 49:877–880PubMedCrossRefGoogle Scholar
  191. 191.
    Zhang HJ, Tan GT, Honag VD, Hung NV, Cuong NM, Soejarto DD, Pezzuto JM, Fong HH (2003) Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea. J Nat Prod 65:1942–1944Google Scholar
  192. 192.
    Szlavik L, Gyuris A, Minarotvis J, Forgo P, Molnar J, Hohmann J (2004) Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. J Planta Med 70:71–873CrossRefGoogle Scholar
  193. 193.
    Ye XY, Ng TB (2001) Peptides from pinto bean and red bean with sequence homology to cowpea 10-kDa protein precursor exhibit antifungal, mitogenic, and HIV-1 reverse transcriptase-inhibitory activities. Biochem Biophys Res Commun 285:424–429PubMedCrossRefGoogle Scholar
  194. 194.
    Min BS, Tomiyamam CM, Nakamura N, Hattori M (2001) Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency Virus-I reverse transcriptase. Chem Pharm Bull 49:546–550PubMedCrossRefGoogle Scholar
  195. 195.
    Jiratchariyakul W, Wiwat C, Vonsakul M, Somanabandhu A, Leelamanit W, Fujii I, Suwannoroj N, Ebizuka W (2001) HIV inhibitor from Thai bitter gourd. Planta Med 67:350–353PubMedCrossRefGoogle Scholar
  196. 196.
    Notka F, Meier GR, Wagner R (2003) Immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Antiviral Res 58:175–186PubMedCrossRefGoogle Scholar
  197. 197.
    Park JC, Hur JM, Park JG, Hatano T, Yoshida T, Miyashiro H, Min BS, Hattori M (2002) Inhibitory effects of Korean medicinal plants and camelliatannin H from Camellia japonica on human immunodeficiency virus type 1. Phytother Res 16:422–426PubMedCrossRefGoogle Scholar
  198. 198.
    Liu S, Jiang S, Wu Z, Lv L, Zhabg J, Zhu Z, Wu S (2002) Identification of an inhibitor of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medical herbs Prunella vulgaris and Rhizoma Cibotte. Life Sci 71:1779–1791PubMedCrossRefGoogle Scholar
  199. 199.
    Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, Kang HB, Kim MJ, Cha JH, Kim YJ, Jun WJ, Lee JM, Yoon HG (2009) Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 69(2):583–592PubMedCrossRefGoogle Scholar
  200. 200.
    Andres A, Donovan SM, Kuhlenschmidt MS (2009) Isoflavones and viral infections. J Nutr Biochem 20:563–569PubMedCrossRefGoogle Scholar
  201. 201.
    Robin V, Irurzun A, Amoros M, Boustie J, Carrasco L (2001) Antipoliovirus flavonoids from Psiadia dentata. Antivir Chem Chemother 12:283–291PubMedGoogle Scholar
  202. 202.
    Hegde VH, Pu H, Patel M, Das PR, Butkiewicz N, Arreaza G, Gullo VP, Chan TM (2003) Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease. Bioorg Med Chem Lett 13:2925PubMedCrossRefGoogle Scholar
  203. 203.
    Clark KJ, Grnat PG, Sarr AB, Belakere JR, Swaggerty CL, Phillips TD, Woode GN (1998) An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections. Vet Microbiol 63:147–157PubMedCrossRefGoogle Scholar
  204. 204.
    Turan K, Nagata K, Kuru A (1996) Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells. Biochem Biophys Res Commun 225:22–26PubMedCrossRefGoogle Scholar
  205. 205.
    Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (2006) Resveratrol inhibition of Varicella-Zoster Virus replication in vitro. Antiviral Res 72:171PubMedCrossRefGoogle Scholar
  206. 206.
    Li BQ, Fu T, Gong WH, Dunlop N, Kung HF, Yan Y, Kang J, Wang JM (2000) The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 49:295PubMedCrossRefGoogle Scholar
  207. 207.
    Mitrocosta D, Mitaku S, Axarlis S, Harvala C, Malamas M (2000) Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med 66:377CrossRefGoogle Scholar
  208. 208.
    Gerencer M, Turecek PL, Kistner O, Mitterer A, Savidis-Dacho H, Barrett NP (2006) In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L. Antiviral Res 72:153PubMedCrossRefGoogle Scholar
  209. 209.
    Rusak G, Krajacic M, Plese N (1997) Inhibition of tomato bushy stunt virus infection using a quercetagetin flavonoid isolated from Centaurea rupestris L. Antiviral Res 36:125PubMedCrossRefGoogle Scholar
  210. 210.
    Sanchez I, Gomez-Garibay F, Taboada J, Ruiz BH (2000) Antiviral effect of flavonoids on the Dengue virus. Phytother Res 14:89PubMedCrossRefGoogle Scholar
  211. 211.
    Kiat TS, Pippen R, Yusof R, Ibrahim H, Khalid N, Rahman NA (2006) Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett 16:3337PubMedCrossRefGoogle Scholar
  212. 212.
    Bae EA, Han MJ, Lee M, Kim DH (2000) In vitro inhibitory effect of some flavonoids on rotavirus infectivity. Biol Pharm Bull 23:1122PubMedCrossRefGoogle Scholar
  213. 213.
    Thamlikitkul V, Wasuwat S, Kanchanapee P (1991) Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers. J Med Assoc Thai 74:381PubMedGoogle Scholar
  214. 214.
    Berk L, de Man RA, Schalm SW, Labadie RP, Heijtink RA (1991) Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. J Hepatol 12:405PubMedCrossRefGoogle Scholar
  215. 215.
    Zhang JL, He WN, Ye P (1992) Clinical observation on Phyllanthus amarus for treating chronic hepatitis B virus infection 1992. Chin J Integr Tradit West Med Liver Dis 2:8Google Scholar
  216. 216.
    Milne A, Hopkirk N, Lucas CR, Waldon J, Foo Y (1994) A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen. N Z Med J 107:253Google Scholar
  217. 217.
    The University of Hong Kong Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs) The Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, the Government of the Hong Kong SAR 2009Google Scholar
  218. 218.
    Huang ZR, Zhong JP, Zhu GL, Chen YR, Wang GQ (1993) Therapeutic observation on Phyllanthus amarus for hepatitis B. Chin J Clin Hepatol 9:108Google Scholar
  219. 219.
    Zhu FM, Zhang JQ, Zhang XZ, Zhang XM (1992) Observation on the effect of Fujian’s Phyllanthus amarus in treatment of HBV infection. Chin J Integr Tradit West Med Liver Dis 2:10Google Scholar
  220. 220.
    Cao WZ, Liu JQ, Cao DY, Su F, Xu SG (1998) Clinical study on anti-HBV activity of Phyllanthus herb from Anhui, China. China J Chin Mater Med 23:180Google Scholar
  221. 221.
    Wang M, Cheng H, Li Y, Meng L, Zhao G, Mai K (1995) Herbs of the genus Phyllanthus in the ­treatment of chronic hepatitis B: observations with three preparations from different geographic sites. J Lab Clin Med 126:350PubMedGoogle Scholar
  222. 222.
    Su X, Chen H, Wang L, Jiang C, Liu J, Zhao M, Ma X, Zhao Y, Han D (1984) The protective effects of Glycyrrhiza glabra against Hepatitis. J Tradit Chin Med 4:127PubMedGoogle Scholar
  223. 223.
    Iino S, Tango T, Matsushima T, Toda G, Miyake K, Hino K, Kumada H, Yasuda K, Kuroki T, Hirayama C, Suzuki H (2001) Amino acid substitutions in S region of hepatitis B virus in the sera from patients with acute hepatitis. Hepatol Res 19:31PubMedCrossRefGoogle Scholar
  224. 224.
    Doshi JC, Vaidya AB, Antarkar DS, Deolalikar R, Antani DH (1994) A two-stage clinical trial of Phyllanthus amarus on hepatitis B carriers: failure to eradicate the surface antigen. Indian J Gastroenterol 13:7PubMedGoogle Scholar
  225. 225.
    Tusenius KJ, Spoek JM, Kramers CW (2001) Iscador Qu for chronic hepatitis C: an exploratory study. Complement Ther Med 9:12PubMedCrossRefGoogle Scholar
  226. 226.
    van Rossum TGJ, Vulto AG, Hop WCJ, Brouwer JT, Niesters HGM, Schalm SW (1999) Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double blind randomized placebo-controlled phase I/II trial. J Gastroenterol Hepatol 14:1093PubMedCrossRefGoogle Scholar
  227. 227.
    Tsubota A, Kumada H, Arase Y, Chayama K, Saitoh S, Ikeda K, Kobayashi M, Suzuki Y, Murashima N (2002) Combined ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis infection: a randomized control trial in 170 patients. Eur J Gastroenterol Hepatol 11:1077CrossRefGoogle Scholar
  228. 228.
    van Rossum TGJ, Vulto AG, Hop WCJ, Schalm SW (2001) Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis. Am J Gastroenterol 96:2432PubMedCrossRefGoogle Scholar
  229. 229.
    Mehrotra R, Rawat S, Kulshreshtha DK (1990) In vitro studies on the effect of certain natural products against hepatitis B virus. Indian J Med Res 92:133PubMedGoogle Scholar
  230. 230.
    Stauder G, Kabil S (1997) Oral enzyme therapy in hepatitis C patients. J Immunother 13:153Google Scholar
  231. 231.
    Suzuki H, Ohta Y, Tekino T, Fujisawa K, Hirayama C (1983) Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis-double blind trial. Asian Med J 26:423Google Scholar
  232. 232.
    Miyake K, Tango T, Ota Y, Mitamura K, Yoshiba M, Kako M, Hayashi S, Ikeda Y, Hayashida N, Iwabuchi S, Sato Y, Tomi T, Funaki N, Hashimoto N, Umeda T, Miyazaki J, Tanaka K, Endo Y, Suzuki H (2002) Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J Gastroenterol Hepatol 17:1198PubMedCrossRefGoogle Scholar
  233. 233.
    Vailaii A, Arista I, Sozze E (1993) Randomized open study of the dose-effect relationship of a short course of IdB1016 in patients with viral or alcoholic hepatitis. Fitoterapia 64:219Google Scholar
  234. 234.
    Narendranathan M, Remla A, Mini PC, Satheesh P (1999) A trial of Phyllanthus amarus in acute viral hepatitis. Trop Gastroenterol 20:164PubMedGoogle Scholar
  235. 235.
    Parés A, Planas R, Torres M, Caballería J, Viver JM, Acero D, Panés J, Rigau J, Santos J, Rodés J (1998) Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 28:731CrossRefGoogle Scholar
  236. 236.
    Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105PubMedCrossRefGoogle Scholar
  237. 237.
    Thom E, Zakay-Rones Z, Wollan T Wadstein J (2002) Randomised study on the efficacy and safety of an oral elderberry extract in the treatment of influenza A and B virus infection. In Proceedings of the 15th international conference on antiviral research, Prague, Czech Republic, March 2002.Google Scholar
  238. 238.
    Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, Mumcuoglu M (1995) Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L) during an outbreak of influenza B Panama. J Altern Complement Med 1:361PubMedCrossRefGoogle Scholar
  239. 239.
    Melchoir J, Palm S, Wikman G (1996) Controlled clinical study of standardized Andrographis paniculata extract (Kan-Jang tablet) in common cold a pilot trial. Phytomedicine 3:315CrossRefGoogle Scholar
  240. 240.
    Caceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK (1999) Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardised Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind placebo study. Phytomedicine 6:217PubMedCrossRefGoogle Scholar
  241. 241.
    Hancke J, Burgos R, Caceres D, Wikman G (1995) A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res 9:559CrossRefGoogle Scholar
  242. 242.
    Josling P (2001) Preventing the common cold with a garlic supplement: a double-blind placebo-controlled survey. Adv Ther 18:189PubMedCrossRefGoogle Scholar
  243. 243.
    Phillpotts RJ, Wallace J, Tyrrell DA, Freestone DS, Shepherd WM (1983) Failure of oral 4′, 6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol 75:115PubMedCrossRefGoogle Scholar
  244. 244.
    Tanamly MD, Tadros F, Labeeb S (2004) Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis 36:752PubMedCrossRefGoogle Scholar
  245. 245.
    Gordon A, Hobbs DA, Bowden DS (2006) Effects of Silybum marianum on serum hepatitis C virus RNA alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol 21:275PubMedCrossRefGoogle Scholar
  246. 246.
    Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y (2005) Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol 39:737PubMedCrossRefGoogle Scholar
  247. 247.
    Strickland GT, Tanamly MD, Tadros F (2005) Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C. Dig Liver Dis 37:542PubMedCrossRefGoogle Scholar
  248. 248.
    El-Zayadi AR, Attia M, Badran HM (2005) Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. Liver Int 25:746PubMedCrossRefGoogle Scholar
  249. 249.
    Koytchev R, Alken RG, Dundarov S (1999) Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 6:225PubMedCrossRefGoogle Scholar
  250. 250.
    Wobling RH, Leonhardt K (1994) Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1:25CrossRefGoogle Scholar
  251. 251.
    Syed TA, Cheema KM, Ashfaq AS, Holt AH Jr (1996) Aloe vera extracts 0.5% in a hydrophilic cream versus Aloe vera gel for the management of genital herpes in males. A placebo-controlled, double-blind, comparative study. J Eur Acad Dermatol Venereol 7:294Google Scholar
  252. 252.
    Syed TA, Afzal M, Ashfaq AS, Holt AH, Ali AS, Ahmad SH (1997) Management of genital herpes in men with 0.5% Aloe vera extract in a hydrophilic cream: a placebo-controlled double-blind study. J Dermatol Treat 8:99CrossRefGoogle Scholar
  253. 253.
    Jayavasu C, Balachandra K, Sangkitporn S, Maharungraungrat A, Thavatsupa P, Bunjob M, Chavalittumrong P, Dechatiwongse N, Ayudhaya T, Sittisomwong N (1992) Clinical trial in the treatment of genital herpes patients. Commun Dis J 18:152Google Scholar
  254. 254.
    Carson CF, Ashton L, Dry L, Smith DW, Riley TV (2001) Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother 48:450PubMedCrossRefGoogle Scholar
  255. 255.
    Saller R, Buechi S, Meyrat R, Schmidhauser C (2001) Combined herbal preparation for topical treatment of Herpes labialis. Forsch Komplementarmed Klass Naturheilkd 8:373PubMedCrossRefGoogle Scholar
  256. 256.
    Sangkitporn S, Chaiwat S, Balachandra K, Na-Ayudhaya TD, Bunjob M, Jayavasu C (1995) Treatment of herpes zoster with Clinacanthus nutans (bi phaya yaw) extract. J Med Assoc Thai 178:624Google Scholar
  257. 257.
    Charuwichitratana S, Wongrattanapasson N, Timpatanapong P, Bunjob M (1996) Herpes zoster: treatment with Clinacanthus nutans cream. Int J Dermatol 35:665PubMedCrossRefGoogle Scholar
  258. 258.
    Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14:333PubMedCrossRefGoogle Scholar
  259. 259.
    Durant J, Chantre G, Gonzalez G, Vandermander J, Halfon P, Rousse B, Guedon D, Rahelinirina V, Chamaret S, Montagnier L, Dellamonica P (1998) Efficacy and safety of Buxus sempervirens L. Preparation ( SPV-30) in HIV infected asymptomatic patients randomized, double-blind, placebo-controlled trial. Phytomedicine 5:1PubMedCrossRefGoogle Scholar
  260. 260.
    Gotoh Y, Tada K, Yamada K, Minamitani M, Negishi M, Fujimaki M, Ikematsu S, Hada M, Mori K, Ito M, Shigeta S, Nakashima H, Yamamoto N, Shiokawa Y (1987) Administration of glycyrrhizin to patients with human immunodeficiency virus infection. Igaku no Ayumi 140:619Google Scholar
  261. 261.
    Gaspar-Marques C, Simões MF, Valdeira ML, Rodríguez B (2008) Terpenoids and phenolics from Plectranthus strigosus, bioactivity screening. Nat Prod Res 22(2):167–177PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Rajesh Naithani
    • 1
  • Rajendra G. Mehta
    • 2
    • 3
  • Deepak Shukla
    • 4
    • 5
  • Susantha N. Chandersekera
    • 6
  • Robert M. Moriarty
    • 2
    • 7
  1. 1.Drug Discovery DivisionIIT Resrach instituteChicagoUSA
  2. 2.Drug Discovery DivisionIIT Research InstituteChicagoUSA
  3. 3.Carcinogenesis Chemoprevention DivisionIIT Research InstituteChicagoUSA
  4. 4.Department of Microbiology and ImmunologyUniversity of IllinoisChicagoUSA
  5. 5.Department of Ophthalmology and Visual SciencesUniversity of IllinoisChicagoUSA
  6. 6.Department of ChemistryUniversity of Illinois at ChicagoChicagoUSA
  7. 7.Department of ChemistryUniversity of IllinoisChicagoUSA

Personalised recommendations